TTOO · T2 Biosystms Inc

-

Please sign in to comment on TTOO

1 Comment

Admin

4 years, 10 months ago

T2 Biosystems, Inc is currently in a long term downtrend where the price is trading 30.7% below its 200 day moving average.

From a valuation standpoint, the stock is 99.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 10.5.

T2 Biosystems, Inc's total revenue rose by 153.8% to $8M since the same quarter in the previous year.

Its net income has increased by 29.4% to $-10M since the same quarter in the previous year.

Finally, its free cash flow grew by 10.0% to $-9M since the same quarter in the previous year.

Based on the above factors, T2 Biosystems, Inc gets an overall score of 4/5.

Exchange	PINK
CurrencyCode	USD
ISIN	US89853L1044
Sector	Healthcare
Industry	Diagnostics & Research

Market Cap	337K
PE Ratio	None
Beta	0.75
Target Price	5
Dividend Yield	None

ABOUT

T2 Biosystms Inc

T2 Biosystems, Inc. engages in the development and commercialization of medical diagnostic products for critical unmet needs in the healthcare. Its products include T2Dx instrument, T2Candida panel, and T2Bacteria panel. The company was incorporated in 2006 and is based in Lexington, Massachusetts.

TTOO · T2 Biosystms Inc

-

T2 Biosystms Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest T2 Biosystms Inc using a moving average strategy